Form 4 for WGS GeneDx Holdings Corp.
Accepted 2025-10-01 00:00:00 ET · period of report 2025-09-30 · accession 0001689575-25-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-10-01 | 2025-09-30 | WGS | Stueland Katherine | CEO, Dir | S - Sale | $108.17 | -12.9K | 2,701 | -83% | -$1.39M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-09-30 | S | D | 200 | $110.23 | 2,501 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-09-30 | S | D | 645 | $111.84 | 1,856 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.50 to $112.04, inclusive. |
| 3 | Common | Class A Common Stock | 2025-09-30 | S | D | 136 | $113.68 | 1,720 | D | — | — | (F8) Following the reported sales effectuated pursuant to a 10b5-1 plan, in addition to the 1,720 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 444,539 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms. |
| 4 | Common | Class A Common Stock | 2025-09-30 | S | D | 606 | $105.10 | 13,972 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.98 to $105.558, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 7. |
| 5 | Common | Class A Common Stock | 2025-09-30 | S | D | 1,092 | $106.69 | 12,880 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.98, inclusive. |
| 6 | Common | Class A Common Stock | 2025-09-30 | S | D | 4,462 | $107.61 | 8,418 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.9955, inclusive. |
| 7 | Common | Class A Common Stock | 2025-09-30 | S | D | 5,163 | $108.55 | 3,255 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.00 to $108.99, inclusive. |
| 8 | Common | Class A Common Stock | 2025-09-30 | S | D | 554 | $109.13 | 2,701 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.00 to $109.3837, inclusive. |